W
Wildtype
Producer of cultivated salmon, bringing sushi-grade fish to market without ocean fishing. FDA safety clearance received May 2025.
Pre-CommercialSeafoodWhole-Cut
$120M
Total Raised
70+
Team Size
2016
Founded
9
Patents
HQ
San Francisco, United States
Technology & Approach
Salmon cell cultivation on plant-based scaffolds to create sushi-grade fillets
Funding History
Series B · 2022-07
$100MLead: L Catterton
Series A · 2020-02
$16MLead: Spark Capital
Key Milestones
- ✓FDA no-questions letter (May 2025)
- ✓Sushi-grade salmon taste tests at top restaurants
- ✓Pilot production facility in San Francisco
Leadership
J
Justin Kolbeck
CEO & Co-Founder
A
Aryé Elfenbein
Co-Founder
Regulatory Status
United StatesApproved
Partnerships
- • Chef partnerships (fine dining)
- • Pokéworks (potential retail)
Related News
Regulatory2025-05-15
Wildtype Receives FDA No-Questions Letter for Cell-Cultured Salmon
Food Navigator